The Roadmap: Belgium
Cardiomyopathies are often neglected despite the significant burden they pose on individuals and society in Belgium and other countries. However, through enhanced awareness, detection, and healthcare provision, the impact and prevalence of those diseases could be reduced.
The Belgian Cardiomyopathies Matter Roadmap aims to address this by raising awareness and ensuring they receive positive policy attention from healthcare system decision-makers and KOLs. This Roadmap transposes the European priorities to the Belgian context to provide a framework for policy changes in Belgium endorsed by leading experts in the field through the Belgian Cardiomyopathies Matter Network.
Launched in February 2024, the Belgian Cardiomyopathies Matter Roadmap was developed with contributions from the following experts of the field of cardiology.
Expert contributors
Prof Stefan Janssens
Chairman, Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
Prof Antoine Bondue
Head of the Department of Cardiology and Rare Disease Director, Hôpital Universitaire de Bruxelles, Hôpital Erasme, ULB
Prof Emeline Van Craenenbroeck
Cardiologist and Coordinator of the Heart Failure Unit, Universitair Ziekenhuis Antwerpen, UZA
News
CMatter Policy Recommendations for the 2024-2029 EU Mandate
In the context of the beginning of the new EU…
CMatter Policy Recommendations for the 2024-2029 EU Mandate
New Infographic: Why EU Cardiovascular Policies Must Tackle Cardiomyopathies We…
Cardiomyopathies Matter 2024 Summit urges more policy action
On 12 November, the Cardiomyopathies Matter 2024 Summit took place,…




